cardiovascular-agents has been researched along with Hypertension--Malignant* in 8 studies
2 review(s) available for cardiovascular-agents and Hypertension--Malignant
Article | Year |
---|---|
[Hypertensive urgencies and emergencies].
Hypertensive urgencies and emergencies are common situations in clinical practice. Hypertensive urgencies are characterized by acute elevation of blood pressure without target organ damage. Hypertensive emergencies are life-threatening situations characterized by acute elevation of blood pressure and target organ damage. The aims of blood pressure control, antihypertensive drugs to use and route of administration will depend on the presence or absence of target organ damage and individual patient characteristics. The correct diagnosis and treatment of these situations are essential for patient prognosis. © 2017 SEHLELHA. Published by Elsevier España, S.L.U. All rights reserved. Topics: Acute Disease; Ambulatory Care; Antihypertensive Agents; Aortic Dissection; Cardiovascular Agents; Cardiovascular Diseases; Catecholamines; Emergencies; Hospitalization; Humans; Hypertension, Malignant; Hypertensive Encephalopathy; Stress, Psychological | 2017 |
[Therapy of hypertensive crises].
Hypertensive crisis is defined as an extreme elevation of arterial blood pressure, with diastolic pressure > 120 mm Hg, and represents an imminent risk to the patient. In such cases, a rapid orientating diagnosis and adequate antihypertensive treatment to avoid sequelae are needed, sometimes even before diagnostic tests are completed. Hypertensive emergencies and hypertensive urgencies can be distinguished. If the critical increase in blood pressure is associated with end-organ damage such as encephalopathy, acute left heart failure and pulmonary edema, angina pectoris, myocardial infarction or dissecting aortic aneurysm, a hypertensive emergency is present, that is an acute threat to the patient's life. A hypertensive emergency requires effective lowering of blood pressure within minutes, but not necessarily to normal range. The choice of suitable antihypertensive agents depends on clinical symptoms, contraindications, duration of pressure elevation and underlying conditions, prior cardiovascular, cerebrovascular and renal disorders. The risk of imminent end-organ damage must be weighed against the risk of rapid blood pressure lowering. In hypertensive urgencies without end-organ complications, blood pressure can be lowered more slowly over several hours, often with oral agents to avoid detrimental fall in blood pressure. The drugs of choice are mainly urapidil i.v. and nitroglycerine. Topics: Cardiovascular Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Emergency Treatment; Humans; Hypertension; Hypertension, Malignant; Time Factors; Vasodilator Agents | 2000 |
6 other study(ies) available for cardiovascular-agents and Hypertension--Malignant
Article | Year |
---|---|
Long-term combined drug therapy in non-malignant hypertension.
Topics: Cardiovascular Agents; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Reserpine | 1958 |
[Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].
Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Pentolinium Tartrate | 1955 |
Methonium treatment of severe and malignant hypertension.
Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central | 1955 |
Results of methonium treatment of hypertensive patients, based on 250 cases treated for periods up to 3 1/2 years including 28 with malignant hypertension.
Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central | 1954 |
[Combines therapy of malignant hypertension].
Topics: Cardiovascular Agents; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Rauwolfia | 1954 |
Hexamethonium and apresoline (L-hydrazinophthalazine) in the treatment of malignant hypertension; report of a case.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Relaxants, Central; Sympatholytics | 1954 |